Radx clinical evaluation services contract TO7. L3 healthcare (project 2620 OTC) and L3 healthcare (project 6658 OTC).
Ended Awarded Last action
- Contract number
- 75N92021F00007
- Awardee
-
National Collegiate Inventors & Innovators Alliance, Inc. UEI D5S9JZ1KDP49
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,476,186
Award facts
- Contract value 100% obligated
- $5,476,185.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Hadley, MA 01035, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,248,725 | |
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $878,823 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,390,080 | |
| Other Administrative Action | $0 | |
| Original award | $4,456,008 |
About this award
The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at approximately $5.5 million to Venturewell (National Collegiate Inventors & Innovators Alliance, Inc.) on September 29, 2021, with completion targeted for September 27, 2022. This firm fixed-price delivery order, issued without set-aside designation, supports clinical evaluation services for the Rapid Acceleration of Diagnostics (RADx) initiative under Venturewell's broader Indefinite Delivery Contract with the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The work is performed at Venturewell's headquarters in Hadley, Massachusetts.
As a non-profit organization with nearly 30 years of experience in innovation program management and technology commercialization, Venturewell has established itself as a critical partner across the NIH enterprise for accelerating diagnostic technology development. Under the RADx initiative, which was launched to expedite the development and commercialization of diagnostics for public health priorities including COVID-19, the organization provides clinical testing and evaluation services for diagnostic devices and platforms. This delivery order represents one of multiple awards Venturewell has received across its RADx-related contract portfolio, which has collectively exceeded $150 million and encompasses award management, commercialization center operations, and clinical evaluation services supporting the nation's diagnostic innovation infrastructure.
Quick answers
Who was awarded contract 75N92021F00007?
75N92021F00007 was awarded to National Collegiate Inventors & Innovators Alliance, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 29, 2021.
How much is contract 75N92021F00007 worth?
The government has obligated $5,476,186 on 75N92021F00007.
Is contract 75N92021F00007 an order under another contract?
Yes. 75N92021F00007 is a delivery order under 75N92021D00008, an indefinite delivery contract.
Was contract 75N92021F00007 competed?
The extent of competition for 75N92021F00007 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award